These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25436839)

  • 1. Bloodstream infections among children with juvenile idiopathic arthritis: a prospective study from the onset of disease.
    Salonen PH; Säilä H; Salonen JH; Vuorela M; Kautiainen H; Lyytikäinen O; Kauppi MJ; Leirisalo-Repo M; Repo H
    Clin Exp Rheumatol; 2014; 32(6):979-83. PubMed ID: 25436839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumonia in children with juvenile idiopathic arthritis in Finland 1999-2014: a nationwide retrospective register linkage study.
    Salonen PH; Säilä H; Salonen JH; Linna M; Helminen M; Kauppi MJ
    Clin Exp Rheumatol; 2018; 36(3):502-507. PubMed ID: 29303705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing trend in the incidence of serious pneumonias in Finnish children with juvenile idiopathic arthritis.
    Salonen PH; Salonen JH; Säilä H; Helminen M; Linna M; Kauppi MJ
    Clin Rheumatol; 2020 Mar; 39(3):853-860. PubMed ID: 31732822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections?
    Arvonen M; Virta LJ; Pokka T; Kröger L; Vähäsalo P
    J Rheumatol; 2015 Mar; 42(3):521-6. PubMed ID: 25320218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
    Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis.
    Esbjörnsson AC; Aalto K; Broström EW; Fasth A; Herlin T; Nielsen S; Nordal E; Peltoniemi S; Rygg M; Zak M; Berntson L;
    Clin Exp Rheumatol; 2015; 33(5):751-7. PubMed ID: 26213158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
    Nimmrich S; Horneff G
    Rheumatol Int; 2015 Mar; 35(3):465-70. PubMed ID: 25583050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt.
    Mourão AF; Santos MJ; Melo Gomes JA; Martins FM; Mendonça SC; Oliveira Ramos F; Fernandes S; Salgado M; Guedes M; Carvalho S; Costa JA; Brito I; Duarte C; Furtado C; Lopes A; Rodrigues A; Sequeira G; Branco JC; Fonseca JE; Canhão H
    Rheumatology (Oxford); 2016 Apr; 55(4):697-703. PubMed ID: 26672905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveitis in Juvenile Idiopathic Arthritis: 18-Year Outcome in the Population-based Nordic Cohort Study.
    Rypdal V; Glerup M; Songstad NT; Bertelsen G; Christoffersen T; Arnstad ED; Aalto K; Berntson L; Fasth A; Herlin T; Ekelund M; Peltoniemi S; Toftedal P; Nielsen S; Leinonen S; Bangsgaard R; Nielsen R; Rygg M; Nordal E;
    Ophthalmology; 2021 Apr; 128(4):598-608. PubMed ID: 32866542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
    Otten MH; Prince FH; Armbrust W; ten Cate R; Hoppenreijs EP; Twilt M; Koopman-Keemink Y; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
    JAMA; 2011 Dec; 306(21):2340-7. PubMed ID: 22056397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis.
    Beukelman T; Xie F; Baddley JW; Chen L; Delzell E; Grijalva CG; Mannion ML; Patkar NM; Saag KG; Winthrop KL; Curtis JR;
    Arthritis Rheum; 2013 May; 65(5):1384-9. PubMed ID: 23460423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-year purchases of disease-modifying drugs of incident patients with chronic juvenile arthritis in Finland.
    Pohjankoski H; Latva K; Kautiainen H; Säilä H; Klaukka T; Virta L; Puolakka K; Pohjolainen T; Savolainen A
    Clin Exp Rheumatol; 2011; 29(5):878-81. PubMed ID: 21961808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of bloodstream infection in an area of Mid-Norway 2002-2013: a prospective population-based observational study.
    Mehl A; Åsvold BO; Lydersen S; Paulsen J; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Mar; 17(1):205. PubMed ID: 28284196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis.
    Pohjankoski H; Kautiainen H; Lauri JV; Puolakka K; Rantalaiho V
    Clin Rheumatol; 2020 Jan; 39(1):263-268. PubMed ID: 31346886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept.
    van Dijken TD; Vastert SJ; Gerloni VM; Pontikaki I; Linnemann K; Girschick H; Armbrust W; Minden K; Prince FH; Kokke FT; Nieuwenhuis EE; Horneff G; Wulffraat NM
    J Rheumatol; 2011 Jul; 38(7):1441-6. PubMed ID: 21459936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan.
    Hsin YC; Zhuang LZ; Yeh KW; Chang CW; Horng JT; Huang JL
    PLoS One; 2015; 10(6):e0128768. PubMed ID: 26047099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment.
    Beukelman T; Xie F; Chen L; Baddley JW; Delzell E; Grijalva CG; Lewis JD; Ouellet-Hellstrom R; Patkar NM; Saag KG; Winthrop KL; Curtis JR;
    Arthritis Rheum; 2012 Aug; 64(8):2773-80. PubMed ID: 22569881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4-year cohorts from 1990-1993 and 2000-2003.
    Kotaniemi K; Sihto-Kauppi K; Salomaa P; Säilä H; Ristolainen L; Kauppi M
    Clin Exp Rheumatol; 2014; 32(1):143-7. PubMed ID: 24351424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and risk factors influence the microbial aetiology of bloodstream infection in children.
    Luthander J; Bennet R; Giske CG; Nilsson A; Eriksson M
    Acta Paediatr; 2013 Feb; 102(2):182-6. PubMed ID: 23121094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
    Aikawa NE; França IL; Ribeiro AC; Sallum AM; Bonfa E; Silva CA
    Vaccine; 2015 Jan; 33(5):604-9. PubMed ID: 25554240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.